Request Deal Involvement

Novo, General Atlantic and Goldman Sachs Asset Management led a Series C round in LePure Biotech.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Paul Weiss Rifkind Wharton & Garrison

legal advisors

Paul Weiss Rifkind Wharton & Garrison

or

Principals

BAYLAND CAPITAL

bidder

BAYLAND CAPITAL

GENERAL ATLANTIC LLC

bidder

GENERAL ATLANTIC LLC

HM CAPITAL PARTNERS

bidder

HM CAPITAL PARTNERS

LEPURE BIOTECH

target

LEPURE BIOTECH

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

GOLDMAN SACHS ASSET MANAGEMENT

bidder

GOLDMAN SACHS ASSET MANAGEMENT

HIGHLIGHT CAPITAL

bidder

HIGHLIGHT CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo, General Atlantic and Goldman Sachs Asset Management led a Series C round in LePure Biotech.